Literature DB >> 31613647

MRI native T1 and T2 mapping of myocardial segments in hypertrophic cardiomyopathy: tissue remodeling manifested prior to structure changes.

Lu Huang1, Lingping Ran1, Peijun Zhao1, Dazhong Tang1, Rui Han2, Tao Ai1, Liming Xia1, Qian Tao3.   

Abstract

OBJECTIVE: The aim of this study was to examine the local myocardial segments in hypertrophic cardiomyopathy (HCM) by MRI T1 and T2 mapping, and to investigate how tissue remodeling correlates with structural and functional remodeling in HCM.
METHODS: 47 patients with HCM and 19 healthy volunteers were enrolled in this study. All subjects underwent cardiac MRI at 3.0 T. Native T1 and T2 values, end-diastolic wall thickness (EDTH), and percentage of systolic wall thickening (PSWT) were assessed in the left ventricular segments according to the American Heart Association model. Myocardial segments were categorized as normal, non-hypertrophic, mild-hypertrophic, moderate-hypertrophic, and severe-hypertrophic based on EDTH. The difference among all five groups, and the correlation between native T1 and T2 values, EDTH, and PSWT were evaluated.
RESULTS: Native T1 and T2 values were significantly elevated in both non-hypertrophic and hypertrophic segments of HCM patients compared to controls (both p < 0.001). PSWT was preserved in non-hypertrophic segments (p = 0.838), while significantly impaired (p < 0.001) in hypertrophic segments. Native T1 value of severe hypertrophic segments in HCM was significantly higher than segments of mild and moderate hypertrophy (p < 0.05).
CONCLUSION: In HCM patients, the non-hypertrophic myocardial segments already demonstrated significantly elevated T1 and T2 values, despite normal wall thickness and preserved contraction function. The finding suggests that tissue remodeling may precede morphological and functional remodeling in HCM. MRI native T1 and T2 mapping can provide additional value for HCM diagnosis at an early stage. ADVANCES IN KNOWLEDGE: Myocardial tissue remodeling, as detected by MRI native T1 and T2 mapping, occurs earlier than morphological and functional changes in HCM patients.

Entities:  

Mesh:

Year:  2019        PMID: 31613647      PMCID: PMC6913362          DOI: 10.1259/bjr.20190634

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  19 in total

1.  Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy.

Authors:  P M Elliott; J R Gimeno Blanes; N G Mahon; J D Poloniecki; W J McKenna
Journal:  Lancet       Date:  2001-02-10       Impact factor: 79.321

2.  Usefulness of Cardiac Magnetic Resonance Imaging to Measure Left Ventricular Wall Thickness for Determining Risk Scores for Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy.

Authors:  Jessica Webb; Adriana Villa; Imane Bekri; Joy Shome; Thomas Teall; Simon Claridge; Tom Jackson; Bradley Porter; Tevfik F Ismail; Gabriella Di Giovine; Christopher A Rinaldi; Gerald Carr-White; Khaled Al-Fakih; Reza Razavi; Amedeo Chiribiri
Journal:  Am J Cardiol       Date:  2017-02-10       Impact factor: 2.778

Review 3.  Hypertrophic cardiomyopathy.

Authors:  Barry J Maron; Martin S Maron
Journal:  Lancet       Date:  2012-08-06       Impact factor: 79.321

Review 4.  Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.

Authors:  Ali J Marian; Eugene Braunwald
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

Review 5.  Risk Stratification in Hypertrophic Cardiomyopathy.

Authors:  Alexandros Klavdios Steriotis; Sanjay Sharma
Journal:  Eur Cardiol       Date:  2015-07

6.  Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis.

Authors:  Leah M Iles; Andris H Ellims; Huw Llewellyn; James L Hare; David M Kaye; Catriona A McLean; Andrew J Taylor
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-10-28       Impact factor: 6.875

7.  Discrepant Measurements of Maximal Left Ventricular Wall Thickness Between Cardiac Magnetic Resonance Imaging and Echocardiography in Patients With Hypertrophic Cardiomyopathy.

Authors:  Waseem Hindieh; Adaya Weissler-Snir; Helene Hammer; Arnon Adler; Harry Rakowski; Raymond H Chan
Journal:  Circ Cardiovasc Imaging       Date:  2017-08       Impact factor: 7.792

8.  Abnormalities in T2-weighted cardiovascular magnetic resonance images of hypertrophic cardiomyopathy: regional distribution and relation to late gadolinium enhancement and severity of hypertrophy.

Authors:  Hassan Abdel-Aty; Myra Cocker; Oliver Strohm; Neil Filipchuk; Matthias G Friedrich
Journal:  J Magn Reson Imaging       Date:  2008-07       Impact factor: 4.813

9.  Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy.

Authors:  P Spirito; P Bellone; K M Harris; P Bernabo; P Bruzzi; B J Maron
Journal:  N Engl J Med       Date:  2000-06-15       Impact factor: 91.245

10.  Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing.

Authors:  Jeanette Schulz-Menger; David A Bluemke; Jens Bremerich; Scott D Flamm; Mark A Fogel; Matthias G Friedrich; Raymond J Kim; Florian von Knobelsdorff-Brenkenhoff; Christopher M Kramer; Dudley J Pennell; Sven Plein; Eike Nagel
Journal:  J Cardiovasc Magn Reson       Date:  2013-05-01       Impact factor: 5.364

View more
  7 in total

1.  Image resampling and discretization effect on the estimate of myocardial radiomic features from T1 and T2 mapping in hypertrophic cardiomyopathy.

Authors:  Daniela Marfisi; Carlo Tessa; Chiara Marzi; Jacopo Del Meglio; Stefania Linsalata; Rita Borgheresi; Alessio Lilli; Riccardo Lazzarini; Luca Salvatori; Claudio Vignali; Andrea Barucci; Mario Mascalchi; Giancarlo Casolo; Stefano Diciotti; Antonio Claudio Traino; Marco Giannelli
Journal:  Sci Rep       Date:  2022-06-17       Impact factor: 4.996

Review 2.  T2 mapping in myocardial disease: a comprehensive review.

Authors:  Aaron T O'Brien; Katarzyna E Gil; Juliet Varghese; Orlando P Simonetti; Karolina M Zareba
Journal:  J Cardiovasc Magn Reson       Date:  2022-06-06       Impact factor: 6.903

Review 3.  The Role of Cardiovascular Magnetic Resonance Imaging in the Evaluation of Hypertrophic Cardiomyopathy.

Authors:  Sanjay Sivalokanathan
Journal:  Diagnostics (Basel)       Date:  2022-01-26

4.  Endogenous T1ρ cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

Authors:  Elizabeth W Thompson; Srikant Kamesh Iyer; Michael P Solomon; Zhaohuan Li; Qiang Zhang; Stefan Piechnik; Konrad Werys; Sophia Swago; Brianna F Moon; Zachary B Rodgers; Anya Hall; Rishabh Kumar; Nosheen Reza; Jessica Kim; Alisha Jamil; Benoit Desjardins; Harold Litt; Anjali Owens; Walter R T Witschey; Yuchi Han
Journal:  J Cardiovasc Magn Reson       Date:  2021-10-25       Impact factor: 5.364

Review 5.  Multimodality Imaging in Cardiomyopathies with Hypertrophic Phenotypes.

Authors:  Emanuele Monda; Giuseppe Palmiero; Michele Lioncino; Marta Rubino; Annapaola Cirillo; Adelaide Fusco; Martina Caiazza; Federica Verrillo; Gaetano Diana; Alfredo Mauriello; Michele Iavarone; Maria Angela Losi; Maria Luisa De Rimini; Santo Dellegrottaglie; Antonello D'Andrea; Eduardo Bossone; Giuseppe Pacileo; Giuseppe Limongelli
Journal:  J Clin Med       Date:  2022-02-07       Impact factor: 4.964

Review 6.  Differential Diagnosis of Thick Myocardium according to Histologic Features Revealed by Multiparametric Cardiac Magnetic Resonance Imaging.

Authors:  Min Jae Cha; Cherry Kim; Chan Ho Park; Yoo Jin Hong; Jae Min Shin; Tae Hoon Kim; Yoon Jin Cha; Chul Hwan Park
Journal:  Korean J Radiol       Date:  2022-05-09       Impact factor: 7.109

Review 7.  Role of CMR Mapping Techniques in Cardiac Hypertrophic Phenotype.

Authors:  Andrea Baggiano; Alberico Del Torto; Marco Guglielmo; Giuseppe Muscogiuri; Laura Fusini; Mario Babbaro; Ada Collevecchio; Rocco Mollace; Stefano Scafuri; Saima Mushtaq; Edoardo Conte; Andrea Daniele Annoni; Alberto Formenti; Maria Elisabetta Mancini; Giulia Mostardini; Daniele Andreini; Andrea Igoren Guaricci; Mauro Pepi; Marianna Fontana; Gianluca Pontone
Journal:  Diagnostics (Basel)       Date:  2020-09-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.